Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes

Background: Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. Objective: The...

Full description

Saved in:
Bibliographic Details
Main Authors: Pulido-Perez, Patricia, Pondigo-de los Angeles, Jorge Alberto, Hernandez-Hernandez, Maria Elena, Torres-Rasgado, Enrique, Romero, Jose R.
Format: Article ou chapitre numérique
Language:Français
Published: 2021
Subjects:
Online Access:Accès Université d'Orléans et IFPM
Accès Université d'Orléans et IFPM
id cairn-MRH_341_0020
record_format cairn
spelling cairn-MRH_341_0020MRHMagnesium Research https://stm.cairn.info/revue-magnesium-research-2021-1-page-20?lang=en https://doi.org/10.1684/mrh.2021.0481 Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes Pulido-Perez, PatriciaPondigo-de los Angeles, Jorge AlbertoHernandez-Hernandez, Maria ElenaTorres-Rasgado, EnriqueRomero, Jose R.2021 glomerular filtration rateSARS-CoV-2serum magnesium levelstype 2 diabetesfre Magnesium Research | 34 | 1 | 2021-01-01 | p. 20-31 | 0953-1424 MRH_34198 Background: Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. Objective: The aim of the study was to investigate the relationship between renal function, serum magnesium levels and mortality in T2D patients with COVID-19. Methods: In this retrospective study, we characterized 118 T2D and non-diabetic subjects hospitalized with COVID-19. Patients were clinically characterized and electrolyte, renal function and inflammatory markers were evaluated. Patients were grouped according to their estimated glomerular filtration rate (eGFR <60 mL/min per 1.73 m²). Results: T2D patients had lower eGFR and serum magnesium levels when compared to non-diabetics (59.7 ± 32.8 vs. 78.4 ± 33.8 mL/min per 1.73 m², P = 0.008 and 1.9 ± 0.3 vs. 2.1 ± 0.3 mEq/L, P = 0.012). Survival was worse in T2D patients with eGFR levels less than 60 mL/min per 1.73 m² as estimated by Kaplan-Meier analyses (log-rank test <0.0001). The Cox model for T2D patients showed that eGFR (HR 0.970, 95% CI 0.949 to 0.991, P = 0.005) and magnesium (HR 8.025, 95% CI 1.226 to 52.512, P = 0.030) were associated with significantly increased risk of death. Conclusion: Reduced eGFR and magnesium levels were associated with increased mortality in our population. These results suggest that early assessment of kidney function, including magnesium levels, may assist in developing effective treatment strategies to reduce morbidity and mortality among Latin American COVID-19 patients with T2D.Cairn free access
language Français
format Article ou chapitre numérique
building 0/Bibliothèque numérique/
1/Bibliothèque numérique/Cairn/
topic glomerular filtration rate
SARS-CoV-2
serum magnesium levels
type 2 diabetes
spellingShingle glomerular filtration rate
SARS-CoV-2
serum magnesium levels
type 2 diabetes
Pulido-Perez, Patricia
Pondigo-de los Angeles, Jorge Alberto
Hernandez-Hernandez, Maria Elena
Torres-Rasgado, Enrique
Romero, Jose R.
Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes
topic_facet glomerular filtration rate
SARS-CoV-2
serum magnesium levels
type 2 diabetes
description Background: Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. Objective: The aim of the study was to investigate the relationship between renal function, serum magnesium levels and mortality in T2D patients with COVID-19. Methods: In this retrospective study, we characterized 118 T2D and non-diabetic subjects hospitalized with COVID-19. Patients were clinically characterized and electrolyte, renal function and inflammatory markers were evaluated. Patients were grouped according to their estimated glomerular filtration rate (eGFR <60 mL/min per 1.73 m²). Results: T2D patients had lower eGFR and serum magnesium levels when compared to non-diabetics (59.7 ± 32.8 vs. 78.4 ± 33.8 mL/min per 1.73 m², P = 0.008 and 1.9 ± 0.3 vs. 2.1 ± 0.3 mEq/L, P = 0.012). Survival was worse in T2D patients with eGFR levels less than 60 mL/min per 1.73 m² as estimated by Kaplan-Meier analyses (log-rank test <0.0001). The Cox model for T2D patients showed that eGFR (HR 0.970, 95% CI 0.949 to 0.991, P = 0.005) and magnesium (HR 8.025, 95% CI 1.226 to 52.512, P = 0.030) were associated with significantly increased risk of death. Conclusion: Reduced eGFR and magnesium levels were associated with increased mortality in our population. These results suggest that early assessment of kidney function, including magnesium levels, may assist in developing effective treatment strategies to reduce morbidity and mortality among Latin American COVID-19 patients with T2D.
author Pulido-Perez, Patricia
Pondigo-de los Angeles, Jorge Alberto
Hernandez-Hernandez, Maria Elena
Torres-Rasgado, Enrique
Romero, Jose R.
author_facet Pulido-Perez, Patricia
Pondigo-de los Angeles, Jorge Alberto
Hernandez-Hernandez, Maria Elena
Torres-Rasgado, Enrique
Romero, Jose R.
author_sort Pulido-Perez, Patricia
title Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes
title_short Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes
title_full Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes
title_fullStr Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes
title_full_unstemmed Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes
title_sort renal function, serum magnesium levels and mortality in covid-19 patients with type 2 diabetes
publishDate 2021
container_title
container_issue
url https://ezproxy.univ-orleans.fr/login?url=https://stm.cairn.info/revue-magnesium-research-2021-1-page-20?lang=en
https://ezproxy.univ-orleans.fr/login?url=https://doi.org/10.1684/mrh.2021.0481
_version_ 1877246235883077632